These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cyclic thrombocytopenia treated by high-dose intravenous immunoglobulin with a favorable response]. Aoki Y; Fujisawa K; Ikegami M; Ishitoya N; Akatsuka J Rinsho Ketsueki; 1988 May; 29(5):705-10. PubMed ID: 3216497 [No Abstract] [Full Text] [Related]
4. Successes and failures of intravenous immunoglobulin. Atrah HI; Crawford RJ; Gabra GS; Mitchell R Scand J Haematol; 1985 Apr; 34(4):345-7. PubMed ID: 4001865 [TBL] [Abstract][Full Text] [Related]
5. Development of immunoglobulin preparations for intravenous use. Barandun S; Isliker H Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252 [No Abstract] [Full Text] [Related]
6. Proceedings of a symposium: Intravenous immunoglobulin therapy of infections in newborns and infants. September 1985, Interlaken, Switzerland. Pediatr Infect Dis; 1986; 5(3 Suppl):S163-219. PubMed ID: 3714522 [No Abstract] [Full Text] [Related]
7. [Combined effect of intravenous human immunoglobulin (GV-523) and antibiotics in severe infections in the fields of internal medicine and surgery]. Mashimo K Kansenshogaku Zasshi; 1983 Aug; 57(8):724-49. PubMed ID: 6420484 [No Abstract] [Full Text] [Related]
8. [Intravenous immunoglobulins in multiple sclerosis. An update]. Schwarz S; Meinck HM; Storch-Hagenlocher B Nervenarzt; 2009 Aug; 80(8):918-28. PubMed ID: 19662451 [TBL] [Abstract][Full Text] [Related]
9. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results]. Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513 [No Abstract] [Full Text] [Related]
11. More insights into the mechanism(s) of the intravenous immunoglobulin effect in autoimmunity. Pollack S Isr J Med Sci; 1992 Feb; 28(2):130-2. PubMed ID: 1559797 [No Abstract] [Full Text] [Related]
12. [Anti-idiotype suppression of autoimmunity by therapeutic intravenous immunoglobulins]. Rossi F; Dietrich G; Kazatchkine M Ann Med Interne (Paris); 1988; 139(5):359-68. PubMed ID: 3144223 [No Abstract] [Full Text] [Related]
13. [Do immunoglobulins have a value and a future in the treatment of severe bacterial infections?]. Baumgartner JD Presse Med; 1990 Feb; 19(5):196-8. PubMed ID: 2137913 [No Abstract] [Full Text] [Related]
14. Newer uses of intravenous immunoglobulins as anti-infective agents. Pennington JE Antimicrob Agents Chemother; 1990 Aug; 34(8):1463-6. PubMed ID: 2221853 [No Abstract] [Full Text] [Related]
15. Comment on the article 'Intravenous immunoglobulins: pharmacological aspects and therapeutic use' by A. Hässig. Rohm D; Stephan W Vox Sang; 1987; 52(1-2):158. PubMed ID: 3604163 [No Abstract] [Full Text] [Related]
16. Positive immunohematologic and serologic test results due to high-dose intravenous immune globulin administration. Garcia L; Huh YO; Fischer HE; Lichtiger B Transfusion; 1987; 27(6):503. PubMed ID: 3318029 [No Abstract] [Full Text] [Related]